DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Narcolepsy - Epidemiology Forecast to 2032
US$ 3,950.00
... cataplexy, cases by clinical manifestation and age-specific diagnosed cases Diagnosed cases of Narcolepsy Key assessments Patient Segmentation Disease Risk & Burden Risk of disease by the segmentation Factors driving growth in a specific patient population
January 2022
60 pages
Natpara - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Natpara API intelligence over Natpara and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Northera - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Northera API intelligence over Northera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ofev - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ofev API intelligence over Ofev and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Olysio - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Olysio API intelligence over Olysio and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Opsumit - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Opsumit API intelligence over Opsumit and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Osphena - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Osphena API intelligence over Osphena and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Otezla - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Otezla API intelligence over Otezla and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Parkinson's Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Pipeline Analysis Parkinson's Disease Market Size and Trends Parkinson's Disease Market Opportunities Impact of upcoming Therapies in Parkinson's Disease Parkinson's Disease Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Parkinson's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Parkinson's Disease Key assessments Patient Segmentation in Parkinson's Disease Parkinson's Disease Risk & Burden Factors driving growth in a specific Parkinson's Disease patient population
January 2022
60 pages
Peripheral T-Cell Lymphoma Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Peripheral T-Cell Lymphoma (PTCL) Key assessments Patient Segmentation in Peripheral T-Cell Lymphoma (PTCL) Peripheral T-Cell Lymphoma (PTCL) Risk & Burden Factors driving growth in a specific Peripheral T-Cell Lymphoma (PTCL ...
January 2022
60 pages
Pomalyst - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pomalyst API intelligence over Pomalyst and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Premarin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Premarin API intelligence over Premarin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Radicava - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Radicava API intelligence over Radicava and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Rapivab - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Rapivab API intelligence over Rapivab and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Requip - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Requip API intelligence over Requip and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Revatio - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Revatio API intelligence over Revatio and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Sovaldi - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Sovaldi API intelligence over Sovaldi and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tafinlar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tafinlar API intelligence over Tafinlar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tecfidera - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tecfidera API intelligence over Tecfidera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tivicay - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Tivicay API intelligence over Tivicay and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Tourette Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Tourette Syndrome Key assessments Patient Segmentation in Tourette Syndrome Tourette Syndrome Risk & Burden Factors driving growth in a specific Tourette Syndrome patient population
January 2022
60 pages
Tourette Syndrome - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Syndrome Pipeline Analysis Tourette Syndrome Market Size and Trends Tourette Syndrome Market Opportunities Impact of upcoming Therapies in Tourette Syndrome Tourette Syndrome Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Unasyn - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Unasyn API intelligence over Unasyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Unisia (Amlodipine + Candesartan) - API Insight, 2022
US$ 500.00
... advantage by identifying the key patent expiry details with respect to Unisia (Amlodipine + Candesartan) API intelligence over Unisia (Amlodipine + Candesartan) and gaining primary intelligence over Active Ingredient manufacturers by country Make more ...
January 2022
30 pages
Varicose Veins - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Varicose Veins Key assessments Patient Segmentation in Varicose Veins Varicose Veins Risk & Burden Factors driving growth in a specific Varicose Veins patient population
January 2022
60 pages
Varicose Veins - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Veins Varicose Veins Pipeline Analysis Varicose Veins Market Size and Trends Varicose Veins Market Opportunities Impact of upcoming Therapies in Varicose Veins Varicose Veins Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Vasculitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Vasculitis Key assessments Patient Segmentation in Vasculitis Vasculitis Risk & Burden Factors driving growth in a specific Vasculitis patient population
January 2022
60 pages
Vasculitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Vasculitis Vasculitis Pipeline Analysis Vasculitis Market Size and Trends Vasculitis Market Opportunities Impact of upcoming Therapies in Vasculitis Vasculitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Vasculitis ...
January 2022
200 pages
Venous Thromboembolism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Venous Thromboembolism Key assessments Patient Segmentation in Venous Thromboembolism Venous Thromboembolism Risk & Burden Factors driving growth in a specific Venous Thromboembolism patient population
January 2022
60 pages
Venous Thromboembolism - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Venous Thromboembolism Report Assessment Current Treatment Practices in Venous Thromboembolism Unmet Needs in Venous Thromboembolism Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Von Willebrand Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Von Willebrand Disease Key assessments Patient Segmentation in Von Willebrand Disease Von Willebrand Disease Risk & Burden Factors driving growth in a specific Von Willebrand Disease patient population
January 2022
60 pages
Von Willebrand Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Von Willebrand Disease Report Assessment Current Treatment Practices in Von Willebrand Disease Unmet Needs in Von Willebrand Disease Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Waldenstrom Macroglobulinemia Key assessments Patient Segmentation in Waldenstrom Macroglobulinemia Waldenstrom Macroglobulinemia Risk & Burden Factors driving growth in a specific Waldenstrom Macroglobulinemia patient population ...
January 2022
60 pages
Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Waldenstrom Macroglobulinemia Report Assessment Current Treatment Practices in Waldenstrom Macroglobulinemia Unmet Needs in Waldenstrom Macroglobulinemia Market Attractiveness Market Drivers and Barriers ...
January 2022
200 pages
Welchol - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Welchol API intelligence over Welchol and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xerostomia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Xerostomia Key assessments Patient Segmentation in Xerostomia Xerostomia Risk & Burden Factors driving growth in a specific Xerostomia patient population
January 2022
60 pages
Xerostomia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Xerostomia Xerostomia Pipeline Analysis Xerostomia Market Size and Trends Xerostomia Market Opportunities Impact of upcoming Therapies in Xerostomia Xerostomia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Xerostomia ...
January 2022
200 pages
Yondelis - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Yondelis API intelligence over Yondelis and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zerbaxa - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zerbaxa API intelligence over Zerbaxa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Insulin Resistance - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Insulin Resistance Key assessments Patient Segmentation in Insulin Resistance Insulin Resistance Risk & Burden Factors driving growth in a specific Insulin Resistance patient population
January 2022
60 pages
Pruritus - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Pruritus Key assessments Patient Segmentation in Pruritus Pruritus Risk & Burden Factors driving growth in a specific Pruritus patient population
January 2022
60 pages
Varicella Zoster (HHV-3) Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Varicella Zoster (HHV-3) Infections Key assessments Patient Segmentation in Varicella Zoster (HHV-3) Infections Varicella Zoster (HHV-3) Infections Risk & Burden Factors driving growth in a specific Varicella Zoster (HHV-3) Infections patient population
January 2022
60 pages
Bacterial Meningitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial Meningitis Key assessments Patient Segmentation in Bacterial Meningitis Bacterial Meningitis Risk & Burden Factors driving growth in a specific Bacterial Meningitis patient population
January 2022
60 pages
Bacterial Meningitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Bacterial Meningitis Report Assessment Current Treatment Practices in Bacterial Meningitis Unmet Needs in Bacterial Meningitis Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
H3N2 Infection - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in H3N2 Infection Key assessments Patient Segmentation in H3N2 Infection H3N2 Infection Risk & Burden Factors driving growth in a specific H3N2 Infection patient population
January 2022
60 pages
Helicobacter Pylori Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Helicobacter Pylori Infections Key assessments Patient Segmentation in Helicobacter Pylori Infections Helicobacter Pylori Infections Risk & Burden Factors driving growth in a specific Helicobacter Pylori Infections patient ...
January 2022
60 pages
Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Hematopoietic Stem Cell Transplantation Key assessments Patient Segmentation in Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Transplantation Risk & Burden Factors driving growth in a specific Hematopoietic Stem Cell Transplantation patient population ...
January 2022
60 pages
Hemophilia B - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemophilia B Key assessments Patient Segmentation in Hemophilia B Hemophilia B Risk & Burden Factors driving growth in a specific Hemophilia B patient population
January 2022
60 pages